​

Beta Bionics (BBNX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BBNX Stock Forecast

Beta Bionics (BBNX) stock forecast, based on 7 Wall Street analysts, predicts a 12-month average price target of $22.38, with a high of $32.00 and a low of $14.00. This represents a 107.22% increase from the last price of $10.80.

BBNX Stock Rating

Beta Bionics stock's rating consensus is Buy, based on 7 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 6 Buy (85.71%), 1 Hold (14.29%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 7 0 1 6 Strong Sell Sell Hold Buy Strong Buy

BBNX Price Target Upside V Benchmarks

TypeNameUpside
StockBeta Bionics107.22%
SectorHealthcare Stocks 15.45%

Price Target Trends

1M3M12M
# Anlaysts-919
Avg Price Target-$23.56$26.63
Last Closing Price$10.80$10.80$10.80
Upside/Downside-118.15%146.57%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 26183--12
Feb, 26173--11
Jan, 26181--10
Dec, 25181--10
Nov, 25181--10
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 18, 2026Lake Street$20.00$12.4560.64%85.19%
Feb 18, 2026Robert W. Baird$14.00$13.970.21%29.63%
Feb 18, 2026Jonathan BlockStifel Nicolaus$22.00$13.9757.48%103.70%
Feb 08, 2026UBS$24.00$13.0883.49%122.22%
Feb 04, 2026Stifel Nicolaus$25.00$14.0677.81%131.48%
Feb 02, 2026Truist Financial$25.00$13.9079.86%131.48%
Jan 26, 2026Cowen & Co.$17.00$15.469.96%57.41%
Jan 15, 2026David RomanGoldman Sachs$25.00$16.9947.15%131.48%
Jan 09, 2026Lake Street$40.00$21.2688.15%270.37%
Dec 18, 2025Richard NewitterTruist Financial$37.00$30.4521.51%242.59%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 08, 2026UBSBuyinitialise
Jan 26, 2026Cowen & Co.Holdinitialise
Jan 15, 2026Goldman SachsBuyBuyhold
Jan 09, 2026Lake StreetBuyBuyhold
Oct 29, 2025Lake StreetBuyBuyhold
Oct 29, 2025Goldman SachsBuyBuyhold
Oct 29, 2025Piper SandlerOverweightOverweighthold
Oct 01, 2025Goldman SachsBuyupgrade

Financial Forecast

EPS Forecast

$-9 $-8 $-7 $-6 $-5 $-4 $-3 $-2 $-1 $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-8.60$-1.81----
Avg Forecast$-2.13$-1.84$-1.96$-2.03$-1.61$-0.95
High Forecast$-1.74$-1.37$-1.52$-0.65$-1.53$-0.90
Low Forecast$-2.75$-2.04$-2.20$-2.72$-1.68$-0.99
Surprise %303.76%-1.63%----

Revenue Forecast

$50M $100M $150M $200M $250M $300M Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$65.12M$100.25M----
Avg Forecast$64.87M$82.68M$111.56M$150.21M$206.79M$270.39M
High Forecast$65.20M$84.80M$116.46M$150.21M$214.26M$280.16M
Low Forecast$63.79M$80.70M$106.20M$150.21M$198.97M$260.17M
Surprise %0.39%21.25%----

Net Income Forecast

$-75M $-60M $-45M $-30M $-15M $0 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28 Dec 29
Dec 24Dec 25Dec 26Dec 27Dec 28Dec 29
Reported$-54.76M$-73.20M----
Avg Forecast$-14.28M$-10.83M$-11.85M$-10.73M$-10.22M$-6.05M
High Forecast$-11.05M$-8.71M$-9.70M$-4.11M$-9.71M$-5.75M
Low Forecast$-17.51M$-12.96M$-13.99M$-17.34M$-10.70M$-6.33M
Surprise %283.51%575.72%----

BBNX Forecast FAQ

Is Beta Bionics stock a buy?

Beta Bionics stock has a consensus rating of Buy, based on 7 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 6 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Beta Bionics is a favorable investment for most analysts.

What is Beta Bionics's price target?

Beta Bionics's price target, set by 7 Wall Street analysts, averages $22.38 over the next 12 months. The price target range spans from $14 at the low end to $32 at the high end, suggesting a potential 107.22% change from the previous closing price of $10.8.

How does Beta Bionics stock forecast compare to its benchmarks?

Beta Bionics's stock forecast shows a 107.22% upside, outperforming the average forecast for the healthcare stocks sector (15.45%).

What is the breakdown of analyst ratings for Beta Bionics over the past three months?

  • March 2026: 8.33% Strong Buy, 66.67% Buy, 25.00% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 9.09% Strong Buy, 63.64% Buy, 27.27% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 10.00% Strong Buy, 80.00% Buy, 10.00% Hold, 0% Sell, 0% Strong Sell.

What is Beta Bionics’s EPS forecast?

Beta Bionics's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.96, marking a 8.29% increase from the reported $-1.81 in 2025. Estimates for the following years are $-2.03 in 2027, $-1.61 in 2028, and $-0.95 in 2029.

What is Beta Bionics’s revenue forecast?

Beta Bionics's average annual revenue forecast for its fiscal year ending in December 2026 is $111.56M, reflecting a 11.28% increase from the reported $100.25M in 2025. The forecast for 2027 is $150.21M, followed by $206.79M for 2028, and $270.39M for 2029.

What is Beta Bionics’s net income forecast?

Beta Bionics's net income forecast for the fiscal year ending in December 2026 stands at $-11.846M, representing a -83.82% decrease from the reported $-73.2M in 2025. Projections indicate $-10.726M in 2027, $-10.216M in 2028, and $-6.047M in 2029.